The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...
Chromium fork named after radioactive element No. 90. Windows and MacOS/Raspi/Android/Special builds are in different repositories, links are towards the top of the ...
Change orientation to land scape to view the price table ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback